Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay.
Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay.
复制标题
使用分支 DNA (bDNA) 信号放大测定对人血清中的 HBV DNA 进行定量。
DOI:
--
复制
发表时间:
1995
影响因子:
3.5
通讯作者:
R. Perrillo
中科院分区:
文献类型:
--
作者:
D. Hendricks;B. J. Stowe;B. Hoo;J. Kolberg;B. Irvine;P. Neuwald;M. Urdea;R. Perrillo
The aim of this study was to establish the performance characteristics of a nonradioisotopic branched DNA (bDNA) signal amplification assay for quantitation of hepatitis B virus (HBV) DNA in human serum. Quantitation was determined from a standard curve and expressed as HBV DNA equivalents/mL (Eq/mL; 285,000 Eq = 1 pg of double stranded HBV DNA). The bDNA assay exhibited a nearly four log dynamic range of quantitation and an analytical detection limit of approximately 100,000 Eq/mL. To ensure a specificity of 99.7%, the quantitation limit was set at 700,000 Eq/mL. The interassay percent coefficient of variance for quantification values ranged from 10% to 15% when performed by novice users with different sets of reagents. Using the bDNA assay, HBV DNA was detected in 94% to 100% of hepatitis B e antigen-positive specimens and 27% to 31% of hepatitis B e antigen-negative specimens from chronic HBV-infected patients. The bDNA assay may be useful as a prognostic and therapy monitoring tool for the management of HBV-infected patients undergoing antiviral treatment.